Administrator Altostrata Posted May 2, 2015 Administrator Share Posted May 2, 2015 The patient had developed akathisia from aripiprazole when it was added to her massive drug cocktail of "clonazepam 1 mg three times a day, citalopram 80 mg/day, trazodone 50 mg at bedtime, and topiramate 100 mg twice daily for migraines.) Four months later, when aripiprazole was discontinued, she developed withdrawal symptoms that sent her to psychiatric ward.http://www.ncbi.nlm.nih.gov/pubmed/24933746R I Med J (2013). 2013 Feb;96(2):13-4.An aripiprazole discontinuation syndrome.Philip NS.AbstractMajor depression is a common and debilitating illness. Over recent years, new pharmacologic treatments have been approved for this disorder, including the atypical antipsychotics. One of the benefits of these medications is their significant efficacy as augmenting agents for unipolar, nonpsychotic major depressive disorder (MDD).Aripiprazole (marketed as Abilify, Bristol-Myers Squibb/ Otsuka Pharmaceuticals) was the first medication of this class approved for adjunctive treatment of MDD, and is the 5th most commonly prescribed medication in the United States in 2010. However, despite the frequency of its use, little has been described regarding events surrounding aripiprazole discontinuation. Here I describe what is, to my knowledge, the first reported case of an aripiprazole discontinuation syndrome. While directly relevant to psychiatrists and behavioral specialists, the symptoms described here are pertinent for internists and neurologists who may encounter this medication in their clinical practice.From full text at http://www.rimed.org/rimedicaljournal/2013/02/2013-02-13-lettertoeditor.pdf : ....the patient reported thatshe had been feeling “restless inside” since aripiprazole ini-tiation, and that this symptom contributed to severe anxi-ety. Aripiprazole was tapered over 48 hours and her akathisiaresolved. Over the following three days her citalopram wastapered to 40 mg, in anticipation of a medication switch.On the fourth day after aripiprazole discontinuation, she re-ported anxiety, irritability, “feeling shaky and jittery,” whichincreased in intensity throughout the day. Physical and motorexaminations were unremarkable and vital signs were stable.A diagnosis of serotonin reuptake inhibitor discontinuationsyndrome was made, and a one-time dose of fluoxetine 20 mgwas given. Lorazepam 1mg prn was provided.These symptoms continued over the following 24 hours.Citalopram was subsequently increased up to 60 mg with noeffect. Lorazepam was only moderately effective, at doses upto 4 mg/day. A presumptive diagnosis of aripiprazole discon-tinuation syndrome was made. She was given aripiprazole 5mg, which resulted in prompt symptomatic improvement. To my knowledge, this is the first report of an “aripiprazolediscontinuation syndrome,” characterized by anxiety andrestlessness without psychomotor findings.....Internet searches of lay-person message boards describe aripiprazole withdrawal, withsimilar reports to those described here. While aripiprazolehas a high rate of discontinuation due to akathisia,6 this isthe first case of discontinuation-induced symptoms. ....Noah S. Philip, MDAssistant Professor of Psychiatry and Human Behavior (clinical),Alpert Medical School of Brown University, Butler Hospital This is not medical advice. Discuss any decisions about your medical care with a knowledgeable medical practitioner. "It has become appallingly obvious that our technology has surpassed our humanity." -- Albert Einstein All postings © copyrighted. Link to comment Share on other sites More sharing options...
Recommended Posts